Low-Dose Endotoxemia and the Acute Phase Response
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Herlev Hospital.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Herlev Hospital
Information provided by:
Herlev Hospital
ClinicalTrials.gov Identifier:
NCT00197899
First received: September 13, 2005
Last updated: December 12, 2005
Last verified: September 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpuse of this study is to examine the acute phase respons when different doses of E. Coli Endotoxin is injected in healty volunters.
Condition | Intervention |
---|---|
Endotoxemia Sepsis |
Drug: E. Coli endotoxin |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double-Blind Primary Purpose: Diagnostic |
Resource links provided by NLM:
Further study details as provided by Herlev Hospital:
Eligibility
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria: Healty volunteers -
Exclusion Criteria:
Infection 14 days prior to the trial Regular medication Present and /or former heart disease -
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00197899
Locations
Denmark | |
Department of Intensive Care | |
Copenhagen, Copenhagen County, Denmark, 2730 |
Sponsors and Collaborators
Herlev Hospital
Investigators
Study Chair: | Bente K Pedersen, MD, DMSc | Department of Infectious Diseases 7641, University Hospital of Copenhagen, H:S Rigshospitalet |
Principal Investigator: | Dorthe H Olsen, MD | Department of Intensive Care, Herlev University Hospital |
Study Director: | Dorthe H Olsen, DM | Department of Intensive Care, Herlev University Hospital |
More Information
No publications provided
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 16, 2012
No publications provided
ClinicalTrials.gov Identifier: | NCT00197899 History of Changes |
Other Study ID Numbers: | KA 04015 |
Study First Received: | September 13, 2005 |
Last Updated: | December 12, 2005 |
Health Authority: | Denmark: The Regional Committee on Biomedical Research Ethics |
Additional relevant MeSH terms:
Acute-Phase Reaction Sepsis Endotoxemia Inflammation Pathologic Processes |
Infection Systemic Inflammatory Response Syndrome Bacteremia Toxemia |
ClinicalTrials.gov processed this record on October 16, 2012